Strong global surveillance through late October 2026 shows no novel pathogen meeting pandemic criteria, with WHO data indicating influenza, SARS-CoV-2, and RSV positivity remaining low or below seasonal thresholds worldwide and no evidence of sustained, widespread human-to-human transmission of a new agent. The ongoing Bundibugyo Ebola outbreak in the Democratic Republic of the Congo remains regionally contained despite cross-border cases, while other reported events such as measles or dengue clusters have not escalated to global scale. With only weeks remaining in the year, trader consensus reflects the absence of conditions for rapid emergence. Realistic shifts could occur from an undetected zoonotic spillover or viral mutation enabling efficient airborne transmission before year-end, though current monitoring thresholds make such scenarios improbable.